Login / Signup

An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism.

Joshua A LeesJoão M DiasFrancis RajamohanJean-Philippe FortinRebecca O'ConnorJimmy X KongEmily A G HughesEthan L FisherJamison B TuttleGabrielle LovettBethany L KormosRayomand J UnwallaLei ZhangAnne-Marie Dechert SchmittDahui ZhouMichael MoranKimberly A StevensKimberly F FennellAlison E VargheseAndrew MaxwellEmmaline E CoteYuan ZhangSeungil Han
Published in: Nature communications (2023)
GPR61 is an orphan GPCR related to biogenic amine receptors. Its association with phenotypes relating to appetite makes it of interest as a druggable target to treat disorders of metabolism and body weight, such as obesity and cachexia. To date, the lack of structural information or a known biological ligand or tool compound has hindered comprehensive efforts to study GPR61 structure and function. Here, we report a structural characterization of GPR61, in both its active-like complex with heterotrimeric G protein and in its inactive state. Moreover, we report the discovery of a potent and selective small-molecule inverse agonist against GPR61 and structural elucidation of its allosteric binding site and mode of action. These findings offer mechanistic insights into an orphan GPCR while providing both a structural framework and tool compound to support further studies of GPR61 function and modulation.
Keyphrases
  • small molecule
  • body weight
  • fatty acid
  • weight loss
  • protein protein
  • type diabetes
  • insulin resistance
  • skeletal muscle
  • anti inflammatory
  • high fat diet induced